Home
Journal Information
About Journal
Founders
Call for Papers
Advantages of Publish
Editorial Office
For Reviewers
Contact Us
Create Account
Login
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2228-5652
eISSN
:
2228-5660
2024, Vol 14, No. 6
×
BioImpacts
Editor-in-Chief
Prof. Khosro Adibkia
Previous
Next
Editorial
1. Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
Jaleh Barar*
, Yadollah Omidi*
Bioimpacts
. 2015;5(2): 65-69.
doi:
10.15171/bi.2015.18
PMCID:
PMC4492186
PMID:
26191499
Scopus ID:
84930410369
Article
PDF
XML
Cited By:
3
0
2
×
Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
Editorial
2. Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities
Nastran Hashemzadeh, Khosro Adibkia
, Jaleh Barar*
Bioimpacts
. 2019;9(1): 1-3.
doi:
10.15171/bi.2019.01
PMCID:
PMC6378097
PMID:
30788254
Scopus ID:
85060480524
Article
PDF
Full Text
XML
Cited By:
5
0
2
×
Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities
Review
3. CRISPR-Cas9 in basic and translational aspects of cancer therapy
Maryam Samareh Salavatipour
, Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei*
Bioimpacts
. 2024;14(6): 30087.
doi:
10.34172/bi.2024.30087
Article
PDF
XML
Cited By:
0
0
0
×
CRISPR-Cas9 in basic and translational aspects of cancer therapy
Submit Your Paper
Instructions for Authors
Aims and Scope
Editorial Board
Editorial Policies
Publication Ethics Policies
Editorial Board Policy
Abstracting and Indexing
Archive
